Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Multi-Omic Approaches Reveal Leukemia Stem Cell Gene Regulatory Mechanisms

Sohini Chakraborty, Hidenori Kasahara, Iryna Berezniuk, Stephen S. Chung, Christopher Y. Park

Blood (2022) 140 (Supplement 1): 5874–5875.

https://doi.org/10.1182/blood-2022-170793

Published: 2022

Journal Articles

Evaluation and Significance of CD25 Expression in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells in Chronic Myelogenous Leukemia Patients

Hidenori Kasahara, MDPhD, Daiki Karigane, MDPhD, Rie Yamazaki, MD, Shinya Fujita, MD, Kouhei Shirosita, MD, Masatoshi Sakurai, MD, Yuya Koda, MD, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD, Takehiko Mori, MD PhD, Yoko Yatabe, Tomoko Arai, Mitsuru Murata, MDPhD, Hiroshi Kobayashi, MD PhD, Keiyo Takubo, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2018) 132 (Supplement 1): 1723.

https://doi.org/10.1182/blood-2018-99-111586

Published: 2018

Journal Articles

Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease

Hidenori Kasahara, MD, Shinichiro Okamoto, MD PhD, Takashi Sekiya, PhD, Akihiko Yoshimura, PhD

Blood (2017) 130 (Supplement 1): 70.

https://doi.org/10.1182/blood.V130.Suppl_1.70.70

Published: 2017

Journal Articles

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Daiki Karigane, MD, Hidenori Kasahara, MD, Masatoshi Sakurai, MD PhD, Eri Matsuki, MD PhD MPH, Keiichi Tozawa, MD, Yuya Koda, MD, Takaaki Toyama, MD, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Takehiko Mori, MD PhD, Yoko Yatabe, Tomoko Arai, Takayuki Mitsuhashi, MD, Mitsuru Murata, MD PhD, Hiroshi Kobayashi, MD PhD, Keiyo Takubo, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 3061.

https://doi.org/10.1182/blood.V128.22.3061.3061

Published: 2016

Journal Articles

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Eri Matsuki, MD PhD MPH, Masatoshi Sakurai, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Taku Kikuchi, MD, Takayuki Shimizu, MD PhD, Kenji Yokoyama, MD PhD, Takehiko Mori, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1887.

https://doi.org/10.1182/blood.V128.22.1887.1887

Published: 2016

Journal Articles

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Masatoshi Sakurai, MD PhD, Takehiko Mori, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Keiichi Tozawa, MD, Eri Matsuki, MD PhD MPH, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1888.

https://doi.org/10.1182/blood.V128.22.1888.1888

Published: 2016

NARROW

Multi-Omic Approaches Reveal Leukemia Stem Cell Gene Regulatory Mechanisms

Evaluation and Significance of CD25 Expression in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells in Chronic Myelogenous Leukemia Patients

Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

Multi-Omic Approaches Reveal Leukemia Stem Cell Gene Regulatory Mechanisms

Evaluation and Significance of CD25 Expression in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells in Chronic Myelogenous Leukemia Patients

Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only